Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT07372612

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07372612
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07372612. Randomized; no masking; primary purpose treatment. Start 2026-01-20 (anticipated); primary completion 2027-10-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms
Condition
Aneurysms
Condition
Flow Diverter
Condition
Middle Cerebral Artery Aneurysm
Condition
Coiling Therapy
Intervention (Procedure)
Flow diverter
Intervention (Procedure)
Stent-assisted coiling
Lead sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (class: other)

Record details

Record id
cardio:ct-nct07372612
Content hash
48239e8fc056c1a0cb757b664a12afa590839b4bdbad61b220c8c17990a6b9a5